| MeSH term | MeSH ID | Detail |
|---|---|---|
| Nervous System Diseases | D009422 | 37 associated lipids |
| Enterocolitis, Pseudomembranous | D004761 | 8 associated lipids |
| Ataxia | D001259 | 20 associated lipids |
| Psoriasis | D011565 | 47 associated lipids |
| Urinary Tract Infections | D014552 | 11 associated lipids |
| Cross Infection | D003428 | 9 associated lipids |
| Pseudomonas Infections | D011552 | 25 associated lipids |
| Staphylococcal Skin Infections | D013207 | 9 associated lipids |
| Wound Infection | D014946 | 12 associated lipids |
| Bacteriuria | D001437 | 7 associated lipids |
erythromycin
erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.
Cross Reference
Introduction
To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with erythromycin?
erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
- Antimicrob. Agents Chemother. (35)
- J. Antimicrob. Chemother. (18)
- J. Pharmacol. Exp. Ther. (2)
- Others (29)
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with erythromycin
PubChem Associated disorders and diseases
What pathways are associated with erythromycin
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with erythromycin?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with erythromycin?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with erythromycin?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with erythromycin?
Related references are published most in these journals:
- Antimicrob. Agents Chemother. (19)
- J. Antimicrob. Chemother. (10)
- Drug Metab. Dispos. (5)
- Others (29)
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with erythromycin?
Mouse Model
Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).
Knock-out
Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with erythromycin
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Dhamdhere G et al. | Interplay between drug efflux and antioxidants in Escherichia coli resistance to antibiotics. | 2010 | Antimicrob. Agents Chemother. | pmid:20876376 |
| Jones RN et al. | In vitro evaluation of three new macrolide antimicrobial agents, RU28965, RU29065, and RU29702, and comparisons with other orally administered drugs. | 1983 | Antimicrob. Agents Chemother. | pmid:6638988 |
| Bingen E et al. | Resistance to macrolides in Streptococcus pyogenes in France in pediatric patients. | 2000 | Antimicrob. Agents Chemother. | pmid:10817692 |
| Entenza JM et al. | Treatment of experimental endocarditis due to erythromycin-susceptible or -resistant methicillin-resistant Staphylococcus aureus with RP 59500. | 1995 | Antimicrob. Agents Chemother. | pmid:7492078 |
| Capobianco JO et al. | Studies of the novel ketolide ABT-773: transport, binding to ribosomes, and inhibition of protein synthesis in Streptococcus pneumoniae. | 2000 | Antimicrob. Agents Chemother. | pmid:10817709 |
| Terashi K et al. | Interactions of ofloxacin and erythromycin with the multidrug resistance protein (MRP) in MRP-overexpressing human leukemia cells. | 2000 | Antimicrob. Agents Chemother. | pmid:10817732 |
| Norris SJ and Edmondson DG | In vitro culture system to determine MICs and MBCs of antimicrobial agents against Treponema pallidum subsp. pallidum (Nichols strain). | 1988 | Antimicrob. Agents Chemother. | pmid:2964810 |
| Drouet M et al. | Endothelial Cell Toxicity of Vancomycin Infusion Combined with Other Antibiotics. | 2015 | Antimicrob. Agents Chemother. | pmid:26055373 |
| Arakawa K et al. | Analysis of the loading and hydroxylation steps in lankamycin biosynthesis in Streptomyces rochei. | 2006 | Antimicrob. Agents Chemother. | pmid:16723550 |
| Dias R et al. | Antimicrobial susceptibility of invasive Streptococcus pneumoniae isolates in Portugal over an 11-year period. | 2006 | Antimicrob. Agents Chemother. | pmid:16723571 |
| Back EE et al. | High rates of perinatal group B Streptococcus clindamycin and erythromycin resistance in an upstate New York hospital. | 2012 | Antimicrob. Agents Chemother. | pmid:22143529 |
| Gaudreau C et al. | Comparison of disk diffusion and agar dilution methods for erythromycin and ciprofloxacin susceptibility testing of Campylobacter jejuni subsp. jejuni. | 2007 | Antimicrob. Agents Chemother. | pmid:17261628 |
| Brenciani A et al. | Genetic elements carrying erm(B) in Streptococcus pyogenes and association with tet(M) tetracycline resistance gene. | 2007 | Antimicrob. Agents Chemother. | pmid:17261630 |
| Rios I et al. | Flavobacterium meningosepticum meningitis: report of selected aspects. | 1978 | Antimicrob. Agents Chemother. | pmid:708021 |
| Nahata MC et al. | Pharmacokinetics of azithromycin in pediatric patients after oral administration of multiple doses of suspension. | 1993 | Antimicrob. Agents Chemother. | pmid:8383944 |
| Vaara M | Outer membrane permeability barrier to azithromycin, clarithromycin, and roxithromycin in gram-negative enteric bacteria. | 1993 | Antimicrob. Agents Chemother. | pmid:8383945 |
| Mertens JC et al. | Double-blind randomized study comparing the efficacies and safeties of a short (3-day) course of azithromycin and a 5-day course of amoxicillin in patients with acute exacerbations of chronic bronchitis. | 1992 | Antimicrob. Agents Chemother. | pmid:1324645 |
| Hammerschlag MR et al. | In vitro activities of azithromycin, clarithromycin, L-ofloxacin, and other antibiotics against Chlamydia pneumoniae. | 1992 | Antimicrob. Agents Chemother. | pmid:1324650 |
| Baltch AL et al. | Inhibitory and bactericidal activities of levofloxacin, ofloxacin, erythromycin, and rifampin used singly and in combination against Legionella pneumophila. | 1995 | Antimicrob. Agents Chemother. | pmid:7486896 |
| Wallace RJ et al. | Disk diffusion testing of susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to antibacterial agents. | 1979 | Antimicrob. Agents Chemother. | pmid:526002 |
| Fernandes PB et al. | New macrolides active against Streptococcus pyogenes with inducible or constitutive type of macrolide-lincosamide-streptogramin B resistance. | 1989 | Antimicrob. Agents Chemother. | pmid:2523688 |
| Labro MT et al. | Interaction of the new ketolide ABT-773 (cethromycin) with human polymorphonuclear neutrophils and the phagocytic cell line PLB-985 in vitro. | 2004 | Antimicrob. Agents Chemother. | pmid:15047507 |
| Kim HB et al. | In vitro activities of 28 antimicrobial agents against Staphylococcus aureus isolates from tertiary-care hospitals in Korea: a nationwide survey. | 2004 | Antimicrob. Agents Chemother. | pmid:15047511 |
| Huang YW et al. | Overexpression of SmeDEF Efflux Pump Decreases Aminoglycoside Resistance in Stenotrophomonas maltophilia. | 2017 | Antimicrob. Agents Chemother. | pmid:28193669 |
| Hardy DJ et al. | Enhancement of the in vitro and in vivo activities of clarithromycin against Haemophilus influenzae by 14-hydroxy-clarithromycin, its major metabolite in humans. | 1990 | Antimicrob. Agents Chemother. | pmid:2143642 |
| Chan YY et al. | BpeAB-OprB, a multidrug efflux pump in Burkholderia pseudomallei. | 2004 | Antimicrob. Agents Chemother. | pmid:15047512 |
| Spigaglia P et al. | ErmB determinants and Tn916-Like elements in clinical isolates of Clostridium difficile. | 2005 | Antimicrob. Agents Chemother. | pmid:15917571 |
| Braga PC et al. | Flow cytometric assessment of susceptibilities of Streptococcus pyogenes to erythromycin and rokitamycin. | 2003 | Antimicrob. Agents Chemother. | pmid:12499226 |
| Raoult D | Use of macrolides for Q fever. | 2003 | Antimicrob. Agents Chemother. | pmid:12499237 |
| Singh KV et al. | Efficacy of telithromycin (HMR 3647) against enterococci in a mouse peritonitis model. | 2000 | Antimicrob. Agents Chemother. | pmid:11083653 |
| Jacobs MR et al. | Antimicrobial susceptibility testing of pneumococci: determination of Kirby-Bauer breakpoints for penicillin G, erythromycin, clindamycin, tetracycline, chloramphenicol, and rifampin. | 1979 | Antimicrob. Agents Chemother. | pmid:39493 |
| Thakker-Varia S et al. | Molecular epidemiology of macrolides-lincosamides-streptogramin B resistance in Staphylococcus aureus and coagulase-negative staphylococci. | 1987 | Antimicrob. Agents Chemother. | pmid:3038007 |
| Farrow KA et al. | Identification of essential residues in the Erm(B) rRNA methyltransferase of Clostridium perfringens. | 2002 | Antimicrob. Agents Chemother. | pmid:11959553 |
| Wolter N et al. | High-level telithromycin resistance in a clinical isolate of Streptococcus pneumoniae. | 2007 | Antimicrob. Agents Chemother. | pmid:17210764 |
| Culebras E et al. | Macrolide and tetracycline resistance and molecular relationships of clinical strains of Streptococcus agalactiae. | 2002 | Antimicrob. Agents Chemother. | pmid:11959603 |
| Bonnet M and Van der Auwera P | Preincubation of Haemophilus influenzae with subinhibitory concentrations of macrolides: influence on human neutrophil chemiluminescence. | 1993 | Antimicrob. Agents Chemother. | pmid:8390808 |
| Izdebski R et al. | Clonal diversity and resistance mechanisms in tetracycline-nonsusceptible Streptococcus pneumoniae isolates in Poland. | 2007 | Antimicrob. Agents Chemother. | pmid:17210772 |
| Laurens C et al. | Clinical and antimicrobial susceptibility data of 140 Streptococcus pseudopneumoniae isolates in France. | 2012 | Antimicrob. Agents Chemother. | pmid:22644030 |
| Allen NE and Epp JK | Mechanism of penicillin-erythromycin synergy on antibiotic-resistant Staphylococcus aureus. | 1978 | Antimicrob. Agents Chemother. | pmid:248271 |
| Wehmeier C et al. | Site-directed mutagenesis reveals amino acid residues in the Escherichia coli RND efflux pump AcrB that confer macrolide resistance. | 2009 | Antimicrob. Agents Chemother. | pmid:18936189 |
| Padilla E et al. | Klebsiella pneumoniae AcrAB efflux pump contributes to antimicrobial resistance and virulence. | 2010 | Antimicrob. Agents Chemother. | pmid:19858254 |
| Tissi L et al. | In vivo efficacy of azithromycin in treatment of systemic infection and septic arthritis induced by type IV group B Streptococcus strains in mice: comparative study with erythromycin and penicillin G. | 1995 | Antimicrob. Agents Chemother. | pmid:8540695 |
| Westerman EL et al. | In vitro activity of josamycin against aerobic gram-positive cocci and anaerobes. | 1976 | Antimicrob. Agents Chemother. | pmid:7189 |
| Rice LB et al. | Tn5384, a composite enterococcal mobile element conferring resistance to erythromycin and gentamicin whose ends are directly repeated copies of IS256. | 1995 | Antimicrob. Agents Chemother. | pmid:7625803 |
| Sakata H et al. | The effect of antimicrobial agents on fecal flora of children. | 1986 | Antimicrob. Agents Chemother. | pmid:3087275 |
| Cinco M et al. | In vitro activity of rokitamycin, a new macrolide, against Borrelia burgdorferi. | 1995 | Antimicrob. Agents Chemother. | pmid:7625812 |
| Noel GJ and Teele DW | In vitro activities of selected new and long-acting cephalosporins against Pasteurella multocida. | 1986 | Antimicrob. Agents Chemother. | pmid:3087279 |
| Hirakata Y et al. | Efficacy of erythromycin lactobionate for treating Pseudomonas aeruginosa bacteremia in mice. | 1992 | Antimicrob. Agents Chemother. | pmid:1416819 |
| Hirakata Y et al. | Potential effects of erythromycin on host defense systems and virulence of Pseudomonas aeruginosa. | 1992 | Antimicrob. Agents Chemother. | pmid:1416882 |
| Khalil H et al. | Synergy between polyethylenimine and different families of antibiotics against a resistant clinical isolate of Pseudomonas aeruginosa. | 2008 | Antimicrob. Agents Chemother. | pmid:18285485 |
| Cochetti I et al. | erm(B)-carrying elements in tetracycline-resistant pneumococci and correspondence between Tn1545 and Tn6003. | 2008 | Antimicrob. Agents Chemother. | pmid:18285489 |
| Lucier TS et al. | Transition mutations in the 23S rRNA of erythromycin-resistant isolates of Mycoplasma pneumoniae. | 1995 | Antimicrob. Agents Chemother. | pmid:8593017 |
| Baltch AL et al. | Antibacterial effects of levofloxacin, erythromycin, and rifampin in a human monocyte system against Legionella pneumophila. | 1998 | Antimicrob. Agents Chemother. | pmid:9835507 |
| Bourne CR et al. | Inhibition of antibiotic-resistant Staphylococcus aureus by the broad-spectrum dihydrofolate reductase inhibitor RAB1. | 2010 | Antimicrob. Agents Chemother. | pmid:20606069 |
| Berry V et al. | Bacteriological efficacies of three macrolides compared with those of amoxicillin-clavulanate against Streptococcus pneumoniae and Haemophilus influenzae. | 1998 | Antimicrob. Agents Chemother. | pmid:9835514 |
| Bohnert JA et al. | Optimized Nile Red efflux assay of AcrAB-TolC multidrug efflux system shows competition between substrates. | 2010 | Antimicrob. Agents Chemother. | pmid:20606071 |
| Murayama SY et al. | Capsular type and antibiotic resistance in Streptococcus agalactiae isolates from patients, ranging from newborns to the elderly, with invasive infections. | 2009 | Antimicrob. Agents Chemother. | pmid:19332682 |
| Durfee MA et al. | Ineffectiveness of erythromycin for treatment of Haemophilus vaginalis-associated vaginitis: possible relationship to acidity of vaginal secretions. | 1979 | Antimicrob. Agents Chemother. | pmid:43114 |
| Webster GF et al. | Suppression of polymorphonuclear leukocyte chemotactic factor production in Propionibacterium acnes by subminimal inhibitory concentrations of tetracycline, ampicillin, minocycline, and erythromycin. | 1982 | Antimicrob. Agents Chemother. | pmid:7049078 |
| Yajko DM et al. | Comparison of the intracellular activities of clarithromycin and erythromycin against Mycobacterium avium complex strains in J774 cells and in alveolar macrophages from human immunodeficiency virus type 1-infected individuals. | 1992 | Antimicrob. Agents Chemother. | pmid:1387302 |
| Yasuda Y et al. | Roxithromycin favorably modifies the initial phase of resistance against infection with macrolide-resistant Streptococcus pneumoniae in a murine pneumonia model. | 2007 | Antimicrob. Agents Chemother. | pmid:17353244 |
| de Lalla F et al. | Clarithromycin-ciprofloxacin-amikacin for therapy of Mycobacterium avium-Mycobacterium intracellulare bacteremia in patients with AIDS. | 1992 | Antimicrob. Agents Chemother. | pmid:1387303 |
| Heller S et al. | Antipropionibacterial activity of BAL19403, a novel macrolide antibiotic. | 2007 | Antimicrob. Agents Chemother. | pmid:17387155 |
| Ji B et al. | Effectiveness of clarithromycin and minocycline alone and in combination against experimental Mycobacterium leprae infection in mice. | 1991 | Antimicrob. Agents Chemother. | pmid:1828136 |
| Stamm LV et al. | In vitro assay to demonstrate high-level erythromycin resistance of a clinical isolate of Treponema pallidum. | 1988 | Antimicrob. Agents Chemother. | pmid:3284454 |
| Baker KR et al. | A High-Throughput Approach To Identify Compounds That Impair Envelope Integrity in Escherichia coli. | 2016 | Antimicrob. Agents Chemother. | pmid:27458225 |
| Azoulay-Dupuis E et al. | Prophylactic and therapeutic activities of azithromycin in a mouse model of pneumococcal pneumonia. | 1991 | Antimicrob. Agents Chemother. | pmid:1656849 |
| Mendes RE et al. | First report of cfr-mediated resistance to linezolid in human staphylococcal clinical isolates recovered in the United States. | 2008 | Antimicrob. Agents Chemother. | pmid:18391032 |
| Amacher DE et al. | Comparison of the effects of the new azalide antibiotic, azithromycin, and erythromycin estolate on rat liver cytochrome P-450. | 1991 | Antimicrob. Agents Chemother. | pmid:1656856 |
| Fass RJ | Erythromycin, clarithromycin, and azithromycin: use of frequency distribution curves, scattergrams, and regression analyses to compare in vitro activities and describe cross-resistance. | 1993 | Antimicrob. Agents Chemother. | pmid:8257127 |
| Jalava J et al. | In vitro activities of the novel ketolide telithromycin (HMR 3647) against erythromycin-resistant Streptococcus species. | 2001 | Antimicrob. Agents Chemother. | pmid:11181362 |
| Koomanachai P et al. | Pharmacodynamic profile of tigecycline against methicillin-resistant Staphylococcus aureus in an experimental pneumonia model. | 2009 | Antimicrob. Agents Chemother. | pmid:19738006 |
| Arhin FF et al. | Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates. | 2009 | Antimicrob. Agents Chemother. | pmid:19738026 |
| Berti MA and Maccari M | Stability of frozen rat plasma containing different antibiotics. | 1975 | Antimicrob. Agents Chemother. | pmid:1211917 |
| Betriu C et al. | Comparative in vitro activities of linezolid, quinupristin-dalfopristin, moxifloxacin, and trovafloxacin against erythromycin-susceptible and -resistant streptococci. | 2000 | Antimicrob. Agents Chemother. | pmid:10858339 |
| Davies TA et al. | Antipneumococcal activity of ABT-773 compared to those of 10 other agents. | 2000 | Antimicrob. Agents Chemother. | pmid:10858350 |
| Kwon DH and Lu CD | Polyamine effects on antibiotic susceptibility in bacteria. | 2007 | Antimicrob. Agents Chemother. | pmid:17438056 |
| Goodman CD et al. | Chemobiosynthesis of new antimalarial macrolides. | 2013 | Antimicrob. Agents Chemother. | pmid:23208707 |
| Segreti J and Kapell KS | In vitro activity of dirithromycin against Chlamydia trachomatis. | 1994 | Antimicrob. Agents Chemother. | pmid:7811051 |
| Reinert RR et al. | In vitro activities of the new ketolide antibiotics HMR 3004 and HMR 3647 against Streptococcus pneumoniae in Germany. | 1998 | Antimicrob. Agents Chemother. | pmid:9624505 |
| Roblin PM and Hammerschlag MR | In vitro activity of a new ketolide antibiotic, HMR 3647, against Chlamydia pneumoniae. | 1998 | Antimicrob. Agents Chemother. | pmid:9624507 |
| Hisatsune J et al. | Emergence of Staphylococcus aureus carrying multiple drug resistance genes on a plasmid encoding exfoliative toxin B. | 2013 | Antimicrob. Agents Chemother. | pmid:24080652 |
| Itoh Z et al. | Gastrointestinal motor-stimulating activity of macrolide antibiotics and analysis of their side effects on the canine gut. | 1984 | Antimicrob. Agents Chemother. | pmid:6524902 |
| van Embden JD et al. | Drug resistance in group D streptococci of clinical and nonclinical origin: prevalence, transferability, and plasmid properties. | 1977 | Antimicrob. Agents Chemother. | pmid:879758 |
| Woosley LN et al. | CEM-101 activity against Gram-positive organisms. | 2010 | Antimicrob. Agents Chemother. | pmid:20176910 |
| Bonnefoy A et al. | In vivo efficacy of the new ketolide telithromycin (HMR 3647) in murine infection models. | 2001 | Antimicrob. Agents Chemother. | pmid:11353612 |
| Morrow BJ et al. | In vitro antibacterial activities of JNJ-Q2, a new broad-spectrum fluoroquinolone. | 2010 | Antimicrob. Agents Chemother. | pmid:20176911 |
| Foleno BD et al. | In vitro antibacterial activity of the pyrrolopyrazolyl-substituted oxazolidinone RWJ-416457. | 2007 | Antimicrob. Agents Chemother. | pmid:17101672 |
| Brophy DF et al. | Pharmacokinetic interaction between amprenavir and clarithromycin in healthy male volunteers. | 2000 | Antimicrob. Agents Chemother. | pmid:10722500 |
| Ono T et al. | Susceptibilities of oral and nasal isolates of Streptococcus mitis and Streptococcus oralis to macrolides and PCR detection of resistance genes. | 2000 | Antimicrob. Agents Chemother. | pmid:10722517 |
| Strigl S et al. | In vitro activity of ABT 773, a new ketolide antibiotic, against Chlamydia pneumoniae. | 2000 | Antimicrob. Agents Chemother. | pmid:10722526 |
| Araujo FG et al. | Azithromycin, a macrolide antibiotic with potent activity against Toxoplasma gondii. | 1988 | Antimicrob. Agents Chemother. | pmid:2840017 |
| Ednie LM et al. | Susceptibilities of 228 penicillin- and erythromycin-susceptible and -resistant pneumococci to RU 64004, a new ketolide, compared with susceptibilities to 16 other agents. | 1997 | Antimicrob. Agents Chemother. | pmid:9145864 |
| Ross JI et al. | Clinical resistance to erythromycin and clindamycin in cutaneous propionibacteria isolated from acne patients is associated with mutations in 23S rRNA. | 1997 | Antimicrob. Agents Chemother. | pmid:9145890 |
| Del Grosso M et al. | New composite genetic element of the Tn916 family with dual macrolide resistance genes in a Streptococcus pneumoniae isolate belonging to clonal complex 271. | 2009 | Antimicrob. Agents Chemother. | pmid:19104015 |
| Schülin T et al. | In vitro activity of RU 64004, a new ketolide antibiotic, against gram-positive bacteria. | 1997 | Antimicrob. Agents Chemother. | pmid:9145901 |
| Di Luca MC et al. | Lysogenic transfer of mef(A) and tet(O) genes carried by Phim46.1 among group A streptococci. | 2010 | Antimicrob. Agents Chemother. | pmid:20643900 |
| Conte JE et al. | Steady-state plasma and intrapulmonary pharmacokinetics and pharmacodynamics of cethromycin. | 2004 | Antimicrob. Agents Chemother. | pmid:15328118 |
| Chollet R et al. | The AcrAB-TolC pump is involved in macrolide resistance but not in telithromycin efflux in Enterobacter aerogenes and Escherichia coli. | 2004 | Antimicrob. Agents Chemother. | pmid:15328143 |
| Andremont A et al. | Epidemiology of intestinal colonization by members of the family Enterobacteriaceae highly resistant to erythromycin in a hematology-oncology unit. | 1986 | Antimicrob. Agents Chemother. | pmid:3729363 |